» Articles » PMID: 32555435

Pelvic Organ Prolapse and Sexual Function

Overview
Journal Nat Rev Urol
Specialty Urology
Date 2020 Jun 20
PMID 32555435
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Sexual dysfunction is one of the symptoms associated with pelvic organ prolapse (POP) that motivates women to seek medical help. Women with POP are likely to restrict sexual activity owing to a perceived of loss of attractiveness and fear of incontinence. Conservative (pelvic floor muscles training or pessary) or surgical management (transabdominally or transvaginally) can be offered to treat POP but questions remain regarding sexual outcome. Despite the usual improvement in sexual function after surgery, a risk of de novo dyspareunia exists irrespective of the procedure used with slightly increased risk after transvaginal repair. Preoperative patient counselling, ideally with a cross-disciplinary approach is an important part of management of POP.

Citing Articles

Anterior Colporrhaphy and Paravaginal Repair for Anterior Compartment Prolapse: A Review.

Tsui W, Ding D Medicina (Kaunas). 2024; 60(11).

PMID: 39597050 PMC: 11596843. DOI: 10.3390/medicina60111865.


Brazilian Portuguese Translation and Validation of the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire-IUGA revised.

Freitas L, Monaco H, Pacetta A, Nahas S, Baracat E, Haddad J Int Urogynecol J. 2024; 35(9):1857-1872.

PMID: 39153070 DOI: 10.1007/s00192-024-05889-y.


Clinical effect and prognostic factor of electric stimulation and biofeedback therapy on postpartum pelvic organ prolapse.

Wu H, Zhong X, He L, Li X, Zeng Y, Jia Y Rev Esc Enferm USP. 2024; 58:e20230421.

PMID: 39115220 PMC: 11308478. DOI: 10.1590/1980-220X-REEUSP-2023-0421en.


Long-Term Self-Management of Vaginal Cube Pessaries Can Improve Sexual Life in Patients with Pelvic Organ Prolapse, Results from a Secondary Analysis.

Nemeth Z, Vida P, Markovic P, Gubas P, Kovacs K, Farkas B Int Urogynecol J. 2024; 35(12):2329-2334.

PMID: 39101959 PMC: 11732951. DOI: 10.1007/s00192-024-05882-5.


Promoting cell proliferation and collagen production with ascorbic acid 2-phosphate-releasing poly(l-lactide-co-ε-caprolactone) membranes for treating pelvic organ prolapse.

Kurki A, Paakinaho K, Hannula M, Karjalainen S, Kuismanen K, Hyttinen J Regen Biomater. 2024; 11:rbae060.

PMID: 38903561 PMC: 11187500. DOI: 10.1093/rb/rbae060.


References
1.
Fatton B . [Sexual outcome after pelvic organ prolapse surgery]. Prog Urol. 2009; 19(13):1037-59. DOI: 10.1016/j.purol.2009.10.001. View

2.
Nygaard I, Barber M, Burgio K, Kenton K, Meikle S, Schaffer J . Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008; 300(11):1311-6. PMC: 2918416. DOI: 10.1001/jama.300.11.1311. View

3.
Achtari C, Dwyer P . Sexual function and pelvic floor disorders. Best Pract Res Clin Obstet Gynaecol. 2005; 19(6):993-1008. DOI: 10.1016/j.bpobgyn.2005.08.012. View

4.
Verbeek M, Hayward L . Pelvic Floor Dysfunction And Its Effect On Quality Of Sexual Life. Sex Med Rev. 2019; 7(4):559-564. DOI: 10.1016/j.sxmr.2019.05.007. View

5.
Rogers R, Rockwood T, Constantine M, Thakar R, Kammerer-Doak D, Pauls R . A new measure of sexual function in women with pelvic floor disorders (PFD): the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR). Int Urogynecol J. 2013; 24(7):1091-103. DOI: 10.1007/s00192-012-2020-8. View